Version history

{
  "session_id": "sess_SDA-2026-04-10-gap-pubmed-20260410-185251-10f6a211",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "minimax:MiniMax-M2.7",
  "action": "synthesize",
  "content": "\n\n```json\n{\n  \"ranked_hypotheses\": [\n    {\n      \"rank\": 1,\n      \"hypothesis_id\": \"H4\",\n      \"title\": \"Cdk5 Phosphorylation of Synaptic Proteins as the Primary Mediator of Cognitive Decline\",\n      \"theorist_confidence\": 0.65,\n      \"skeptic_reassessment\": 0.55,\n      \"composite_score\": 0.60,\n      \"scoring\": {\n        \"mechanistic_plausibility\": 0.78,\n        \"evidence_strength\": 0.65,\n        \"novelty\": 0.72,\n        \"feasibility\": 0.68,\n        \"therapeutic_potential\": 0.75,\n        \"druggability\": 0.52,\n        \"safety_profile\": 0.48,\n        \"competitive_landscape\": 0.85,\n        \"data_availability\": 0.72,\n        \"reproducibility\": 0.70\n      },\n      \"evidence_for\": [\n        {\"claim\": \"Cdk5 phosphorylates PSD-95 at Ser561, disrupting synaptic targeting and glutamatergic transmission\", \"pmid\": \"19279202\"},\n        {\"claim\": \"Cdk5-mediated NR2B phosphorylation at Ser1116 increases NMDA receptor internalization and excitotoxicity\", \"pmid\": \"15142982\"},\n        {\"claim\": \"Conditional Cdk5 knockout in forebrain neurons causes impaired spatial memory before tau pathology appears\", \"pmid\": \"16888024\"},\n        {\"claim\": \"Cdk5 phosphorylates Synapsin-1, regulating synaptic vesicle mobilization\", \"pmid\": \"10618395\"},\n        {\"claim\": \"Synaptic Cdk5 substrates (PSD-95, NR2B) are non-redundant targets with established roles in memory\", \"pmid\": \"19797614\"}\n      ],\n      \"evidence_against\": [\n        {\"claim\": \"Many Cdk5 substrates (NMDA receptors, AMPA receptors) are also phosphorylated by other kinases like CaMKII, reducing specificity\", \"pmid\": \"11438544\"},\n        {\"claim\": \"Cdk5-independent Aβ toxicity documented through JNK3 activation and caspase-12 pathways\", \"pmid\": \"11836528\"},\n        {\"claim\": \"Conditional knockout approaches are confounded by developmental compensation mechanisms\", \"pmid\": \"11278588\"},\n        {\"claim\": \"Synaptic deficits may occur through parallel pathways independent of Cdk5\", \"pmid\": \"17382203\"}\n      ],\n      \"drug_development_assessment\": \"HIGH potential if selective inhibitors can be developed; synapse-sparing approach addresses developmental toxicity concern. Compound 6 (Pfizer, Ki ~6 nM) represents best chemical matter but not progressed.\",\n      \"knowledge_edges\": [\n        {\"source\": \"CDK5\", \"relation\": \"phosphorylates\", \"target\": \"PSD-95\", \"pmid\": \"19279202\"},\n        {\"source\": \"CDK5\", \"relation\": \"phosphorylates\", \"target\": \"NR2B\", \"pmid\": \"15142982\"},\n        {\"source\": \"CDK5\", \"relation\": \"phosphorylates\", \"target\": \"Synapsin-1\", \"pmid\": \"10618395\"},\n        {\"source\": \"CDK5\", \"relation\": \"regulates\", \"target\": \"glutamate_signaling\", \"pmid\": \"19797614\"},\n        {\"source\": \"Cognitive_decline\", \"relation\": \"precedes\", \"target\": \"tangle_pathology\", \"pmid\": \"16888024\"}",
  "tokens_used": "689",
  "persona_id": "persona-synthesizer"
}